vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Madison Square Garden Entertainment Corp. (MSGE). Click either name above to swap in a different company.
Madison Square Garden Entertainment Corp. is the larger business by last-quarter revenue ($424.8M vs $284.0M, roughly 1.5× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 21.8%, a 74.5% gap on every dollar of revenue. On growth, Madison Square Garden Entertainment Corp. posted the faster year-over-year revenue change (12.5% vs 9.4%). Over the past eight quarters, Madison Square Garden Entertainment Corp.'s revenue compounded faster (48.9% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Madison Square Garden Sports Corp. is an American sports holding company based in New York City.
ACAD vs MSGE — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $424.8M |
| Net Profit | $273.6M | $92.7M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 38.6% |
| Net Margin | 96.3% | 21.8% |
| Revenue YoY | 9.4% | 12.5% |
| Net Profit YoY | 90.3% | 22.2% |
| EPS (diluted) | $1.61 | $1.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $424.8M | ||
| Q3 25 | $278.6M | $154.1M | ||
| Q2 25 | $264.6M | $145.1M | ||
| Q1 25 | $244.3M | $206.0M | ||
| Q4 24 | $259.6M | $377.6M | ||
| Q3 24 | $250.4M | $134.1M | ||
| Q2 24 | $242.0M | $177.6M | ||
| Q1 24 | $205.8M | $191.6M |
| Q4 25 | $273.6M | $92.7M | ||
| Q3 25 | $71.8M | $-21.7M | ||
| Q2 25 | $26.7M | $-27.2M | ||
| Q1 25 | $19.0M | $8.0M | ||
| Q4 24 | $143.7M | $75.9M | ||
| Q3 24 | $32.8M | $-19.3M | ||
| Q2 24 | $33.4M | $66.9M | ||
| Q1 24 | $16.6M | $2.8M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 38.6% | ||
| Q3 25 | 12.8% | -19.3% | ||
| Q2 25 | 12.2% | -17.7% | ||
| Q1 25 | 7.9% | 13.3% | ||
| Q4 24 | 59.1% | 36.8% | ||
| Q3 24 | 12.6% | -13.8% | ||
| Q2 24 | 12.6% | -5.0% | ||
| Q1 24 | 7.4% | 8.8% |
| Q4 25 | 96.3% | 21.8% | ||
| Q3 25 | 25.8% | -14.0% | ||
| Q2 25 | 10.1% | -18.7% | ||
| Q1 25 | 7.8% | 3.9% | ||
| Q4 24 | 55.4% | 20.1% | ||
| Q3 24 | 13.1% | -14.4% | ||
| Q2 24 | 13.8% | 37.7% | ||
| Q1 24 | 8.0% | 1.5% |
| Q4 25 | $1.61 | $1.94 | ||
| Q3 25 | $0.42 | $-0.46 | ||
| Q2 25 | $0.16 | $-0.56 | ||
| Q1 25 | $0.11 | $0.17 | ||
| Q4 24 | $0.86 | $1.56 | ||
| Q3 24 | $0.20 | $-0.40 | ||
| Q2 24 | $0.20 | $1.32 | ||
| Q1 24 | $0.10 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $157.1M |
| Total DebtLower is stronger | — | $554.6M |
| Stockholders' EquityBook value | $1.2B | $36.0M |
| Total Assets | $1.6B | $1.8B |
| Debt / EquityLower = less leverage | — | 15.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $157.1M | ||
| Q3 25 | $258.0M | $29.9M | ||
| Q2 25 | $253.6M | $43.0M | ||
| Q1 25 | $217.7M | $89.0M | ||
| Q4 24 | $319.6M | $54.9M | ||
| Q3 24 | $155.1M | $37.3M | ||
| Q2 24 | $177.1M | $33.3M | ||
| Q1 24 | $204.7M | $28.0M |
| Q4 25 | — | $554.6M | ||
| Q3 25 | — | $581.7M | ||
| Q2 25 | — | $568.8M | ||
| Q1 25 | — | $577.4M | ||
| Q4 24 | — | $584.7M | ||
| Q3 24 | — | $647.0M | ||
| Q2 24 | — | $599.2M | ||
| Q1 24 | — | $602.5M |
| Q4 25 | $1.2B | $36.0M | ||
| Q3 25 | $917.3M | $-65.8M | ||
| Q2 25 | $822.4M | $-13.3M | ||
| Q1 25 | $765.2M | $9.5M | ||
| Q4 24 | $732.8M | $10.3M | ||
| Q3 24 | $577.2M | $-48.7M | ||
| Q2 24 | $516.7M | $-23.2M | ||
| Q1 24 | $464.0M | $-94.6M |
| Q4 25 | $1.6B | $1.8B | ||
| Q3 25 | $1.3B | $1.7B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.1B | $1.7B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $976.9M | $1.6B | ||
| Q2 24 | $914.1M | $1.6B | ||
| Q1 24 | $855.1M | $1.5B |
| Q4 25 | — | 15.40× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 60.61× | ||
| Q4 24 | — | 56.61× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $164.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | 1.77× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $164.4M | ||
| Q3 25 | $74.3M | $19.8M | ||
| Q2 25 | $64.0M | $-27.0M | ||
| Q1 25 | $20.3M | $56.8M | ||
| Q4 24 | $40.4M | $112.9M | ||
| Q3 24 | $63.2M | $-27.4M | ||
| Q2 24 | $25.0M | $212.0K | ||
| Q1 24 | $29.1M | $5.8M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.18× | 1.77× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | 7.07× | ||
| Q4 24 | 0.28× | 1.49× | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 0.00× | ||
| Q1 24 | 1.76× | 2.08× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
MSGE
| Ticketing And Venue License Fee Revenues | $263.5M | 62% |
| Food Beverage And Merchandise Revenues | $64.3M | 15% |
| Related Party | $43.9M | 10% |
| Arena Licensing Fees And Other Leasing Revenue | $35.2M | 8% |
| Other | $15.9M | 4% |
